Epilepsy Hero Image

A type of neurological disorder characterized by recurrent seizures—transient neurological abnormalities caused by abnormal activity in the brain—or temporary alteration in one or more brain functions.


LATEST ARTICLES

  • Taking Control of Epilepsy image

    Taking Control of Epilepsy

    As the most common serious neurological condition in the U.S., epilepsy affects roughly 3.4 million Americans. It's what drives biopharmaceutical researchers to fight back with innovative medicines like targeted treatments that could transform the lives of patients living with the disease.

  • Pursuing Novel and Targeted Treatments for Epilepsy image

    Pursuing Novel and Targeted Treatments for Epilepsy

    Epilepsy is a complex condition, and it will take an equally complex approach to put an end to the disease. America's biopharmaceutical companies will not be satisfied until that goal is reached.

  • Tackling Epilepsy to Deliver Value to Patients

    Tackling Epilepsy to Deliver Value to Patients

    Brain diseases affect one in six people around the world. The range of conditions affecting the central nervous system – and how they impact the patient – is wide, making unlocking the science behind them complicated.


RELATED ARTICLES

Your Epilepsy Does Not Define You image

Your Epilepsy Does Not Define You

Epilepsy patient, caregiver and advocate Loretta Boileau has seen firsthand the benefits of innovative treatments for her and her family, but knows there is still a long road ahead.

Researcher Profile: Eddy Han-Burgess image

Researcher Profile: Eddy Han-Burgess

Eddy Han-Burgess and his team are using a mix of mathematical modeling, big data and artificial intelligence in hopes of more quickly identifying the unique characteristics of someone’s condition.

Researcher Profile: Henrik Klitgaard image

Researcher Profile: Henrik Klitgaard

With nearly 30 years of experience in biopharmaceutical research, Dr. Henrik Klitgaard has dedicated his life to pursuing new and better treatments for patients with epilepsy.